DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea · Delayed Price · Currency is KRW 4,340.00
-15.00 (-0.34%)
Sep 19, 2025, 3:30 PM KST
DK Life Science Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | 8,055 | 2,245 | 4,167 | 4,239 | 5,858 | 4,455 | Upgrade |
Depreciation & Amortization | 6,138 | 5,782 | 3,283 | 2,461 | 2,385 | 2,089 | Upgrade |
Loss (Gain) From Sale of Assets | -82.5 | -9.63 | -749.93 | - | 34.43 | - | Upgrade |
Loss (Gain) From Sale of Investments | -170.67 | -49.07 | 1,670 | -321.86 | -298.74 | -347.7 | Upgrade |
Provision & Write-off of Bad Debts | 340.89 | -158.65 | 567.79 | 236.61 | -707.6 | 1,785 | Upgrade |
Other Operating Activities | 4,152 | 9,393 | 3,369 | 2,936 | -1,109 | 3,685 | Upgrade |
Change in Accounts Receivable | -13,905 | -6,540 | -10,317 | -1,664 | 3,990 | -13,070 | Upgrade |
Change in Inventory | 10,967 | -2,773 | -10,815 | -9,311 | -7,843 | -3,319 | Upgrade |
Change in Accounts Payable | -6,253 | 2,916 | 6,279 | 3,834 | 178.79 | 5,456 | Upgrade |
Change in Other Net Operating Assets | -1,027 | 730.77 | -2,061 | -5,326 | -3,910 | 547.57 | Upgrade |
Operating Cash Flow | 8,215 | 11,536 | -4,608 | -2,916 | -1,424 | 1,281 | Upgrade |
Operating Cash Flow Growth | - | - | - | - | - | -68.04% | Upgrade |
Capital Expenditures | -5,104 | -5,081 | -4,791 | -17,371 | -23,315 | -16,307 | Upgrade |
Sale of Property, Plant & Equipment | 116.39 | 27.3 | 3,578 | 55.92 | 3.72 | - | Upgrade |
Sale (Purchase) of Intangibles | - | - | - | -8.14 | -5,349 | -189.58 | Upgrade |
Investment in Securities | -10,112 | -2,374 | 4,200 | -1,214 | -1,731 | -36 | Upgrade |
Other Investing Activities | 65.45 | 30.52 | 397.4 | -250.64 | -31.22 | 78.92 | Upgrade |
Investing Cash Flow | -14,946 | -7,357 | 3,418 | -18,731 | -30,284 | -16,413 | Upgrade |
Short-Term Debt Issued | - | 18,000 | 10,500 | 6,100 | 10,000 | 3,000 | Upgrade |
Long-Term Debt Issued | - | 22,900 | - | 15,000 | 10,000 | - | Upgrade |
Total Debt Issued | 55,827 | 40,900 | 10,500 | 21,100 | 20,000 | 3,000 | Upgrade |
Short-Term Debt Repaid | - | -18,600 | -4,000 | -3,000 | -1,600 | -3,163 | Upgrade |
Long-Term Debt Repaid | - | -25,428 | -1,332 | -418.16 | -376.35 | -439.08 | Upgrade |
Total Debt Repaid | -62,922 | -44,028 | -5,332 | -3,418 | -1,976 | -3,602 | Upgrade |
Net Debt Issued (Repaid) | -7,095 | -3,128 | 5,168 | 17,682 | 18,024 | -602.49 | Upgrade |
Issuance of Common Stock | 18,540 | - | - | - | - | - | Upgrade |
Other Financing Activities | -3,416 | -2,072 | -1,935 | -1,169 | -259 | -122.91 | Upgrade |
Financing Cash Flow | 8,029 | -5,199 | 3,233 | 16,513 | 17,765 | 27,746 | Upgrade |
Foreign Exchange Rate Adjustments | -126.32 | - | - | -38.05 | 59.78 | 23.93 | Upgrade |
Net Cash Flow | 1,172 | -1,021 | 2,043 | -5,172 | -13,883 | 12,637 | Upgrade |
Free Cash Flow | 3,112 | 6,455 | -9,398 | -20,287 | -24,739 | -15,026 | Upgrade |
Free Cash Flow Margin | 2.32% | 4.90% | -7.82% | -18.92% | -24.10% | -13.71% | Upgrade |
Free Cash Flow Per Share | 188.18 | 503.21 | -839.06 | -18122.49 | -22100.17 | -13147.89 | Upgrade |
Cash Interest Paid | 2,736 | 2,072 | 1,935 | 1,169 | 259 | 122.91 | Upgrade |
Cash Income Tax Paid | 2,127 | 580.17 | 831.35 | 153.46 | 2,904 | 1,512 | Upgrade |
Levered Free Cash Flow | - | -377.79 | -16,751 | -30,438 | -28,800 | -2,511 | Upgrade |
Unlevered Free Cash Flow | - | 1,744 | -13,630 | -28,176 | -27,275 | -1,649 | Upgrade |
Change in Working Capital | -10,218 | -5,666 | -16,915 | -12,467 | -7,585 | -10,385 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.